Home/Filings/4/0001127602-24-028011
4//SEC Filing

ROBBINS LARRY 4

Accession 0001127602-24-028011

CIK 0000064803other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 6:10 PM ET

Size

9.7 KB

Accession

0001127602-24-028011

Insider Transaction Report

Form 4
Period: 2024-11-21
Transactions
  • Award

    Deferred Stock Units

    2024-11-21$57.10/sh+2,933.45$167,5002,933.45 total
    Exercise: $0.00Common Stock (2,933.45 underlying)
Holdings
  • Common Stock

    (indirect: Held by Glenview Investment Funds)
    11,946,799
  • Cash-Settled Swaps

    (indirect: Held by Glenview InvestmentFunds)
    Exercise: $0.00From: 2024-08-16Exp: 2027-09-16Common Stock (378,000 underlying)
    378,000
Footnotes (7)
  • [F1]These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (the "Glenview Investment Funds").
  • [F2]The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
  • [F3]The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.
  • [F4]These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund.
  • [F5]The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps.
  • [F6]Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan.
  • [F7]Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001228603

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 6:10 PM ET
Size
9.7 KB